4.8 Letter

Variable cellular responses to SARS-CoV-2 in fully vaccinated patients with multiple myeloma

Related references

Note: Only part of the references are listed.
Article Oncology

Response to mRNA vaccination for COVID-19 among patients with multiple myeloma

Samuel D. Stampfer et al.

Summary: Patients with multiple myeloma have impaired responses to mRNA vaccination against COVID-19, with those with active disease showing poorer responses. Factors such as age, renal function, immunoglobulin levels, among others, can predict vaccine responsiveness in these patients. Additionally, patients vaccinated with mRNA-1273 had higher anti-spike antibody levels compared to those vaccinated with BNT162b2.

LEUKEMIA (2021)

Article Biochemistry & Molecular Biology

Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy

Sokratis A. Apostolidis et al.

Summary: Patients with multiple sclerosis on anti-CD20 monotherapy exhibit significantly reduced SARS-CoV-2-specific antibodies and memory B cells, while CD4(+) and CD8(+) T cells are robustly activated compared to healthy controls after receiving BNT162b2 or mRNA-1273 mRNA vaccination.

NATURE MEDICINE (2021)

Article Immunology

Reactive T Cells in Convalescent COVID-19 Patients With Negative SARS-CoV-2 Antibody Serology

Sophie Steiner et al.

Summary: This study revealed the presence of nucleocapsid-reactive T cells in some convalescent COVID-19 patients despite the absence of detectable SARS-CoV-2 antibodies. These T cells play an important role in viral control, highlighting their significance even in the absence of specific antibodies.

FRONTIERS IN IMMUNOLOGY (2021)

Review Oncology

COVID-19 and Cancer: Current Challenges and Perspectives

Ziad Bakouny et al.

CANCER CELL (2020)

Article Biochemistry & Molecular Biology

Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19

Takuya Sekine et al.

Article Multidisciplinary Sciences

Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults

Mark J. Mulligan et al.

NATURE (2020)

Article Immunology

Polyfunctional T cell responses are a hallmark of HIV-2 infection

Melody G. Duvall et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2008)